Most top killers are diet-driven and largely reversible

1

Killers before nutrients

Ordering chapters by the fifteen leading causes of death makes food the central lever against real mortality instead of a wellness side topic.

Greger refuses to open with antioxidants or omega-3 hype. He lines the first half up with CDC killers: heart disease, lung disease, brain disease, digestive cancers, infections, diabetes, high blood pressure, liver disease, blood cancers, kidney disease, breast cancer, suicidal depression, prostate cancer, Parkinson’s, and iatrogenic harm.

That sequence is the argument. Heart disease alone accounts for roughly 600,000 American deaths a year, more than the next several causes combined, so he starts where the diet link is oldest. The reader is pushed to ask what actually kills people in their risk category and what in the diet drives it.

Only after that disease-by-disease case does he pivot to a single food system meant to hit all of them at once. Structure itself does the persuading before any checklist appears.

In practice: He opens on heart disease with the Lyon Diet Heart Study and Ornish’s Lifestyle Heart Trial showing arterial reversal from diet change without drugs.

2

Heart disease is optional

Coronary disease is a food-caused condition that can be prevented and reversed by cutting animal fat and processed food, not an aging tax.

Greger’s centerpiece claim is that heart disease barely exists in populations eating traditional whole-food plant diets. Korean and Vietnam War autopsies found serious plaque in young American soldiers who had no symptoms, while rural China data he cites showed heart attacks nearly unheard of.

The mechanism he stresses is endothelial function. Saturated fat and cholesterol from meat, dairy, and eggs impair vessel lining within hours, measurable on flow-mediated dilation tests. Ornish and Esselstyn protocols that barred oil, meat, and dairy produced shrinking blockages and disappearing angina even in severe, drug-resistant cases.

Esselstyn’s small long-term cohort had almost no further cardiac events among people who stuck with the diet. Greger admits these are not huge randomized trials, yet argues population patterns, biology, and case series align tightly enough to act. This chapter becomes the template for every disease that follows.

In practice: Esselstyn’s adherent patients with severe angina saw blockages shrink and cardiac events nearly vanish over more than a decade.

3

Cancer: skip more than add

Cancer risk bends more by avoiding animal protein, processed meat, and high-heat meat carcinogens than by chasing miracle foods.

Greger softens his tone here because cancer is many diseases, not one switch. He highlights the WHO’s 2015 call on processed meat as a Group 1 carcinogen and red meat as probable Group 2A, tied to heterocyclic amines and polycyclic aromatic hydrocarbons formed when meat is grilled, fried, or smoked.

Animal protein elevates IGF-1, a growth signal he links, via Longo’s work, to faster cancer-cell proliferation. For breast and prostate cancer he points to flax lignans and cruciferous compounds like sulforaphane; preoperative flax use was associated with better tumor markers before surgery.

He repeatedly frames diet as risk modification, not cure, and notes how rare long dietary prevention trials are. Confidence is visibly thinner than in the heart chapter, even when the prose stays firm. The lasting practical line is that cutting processed and charred meat matters at least as much as adding any protective plant.

In practice: Patients given flaxseed before breast cancer surgery showed reduced tumor markers in the weeks before the operation.

4

Diabetes is a fat problem

Type 2 diabetes comes chiefly from fat inside muscle and liver cells blocking insulin, so low-fat plant diets can beat sugar restriction alone.

Greger rejects the everyday story that diabetes is mainly a sugar disease. NIH-linked work he cites shows fat inside muscle and liver cells interferes with the insulin receptor’s ability to clear glucose from blood, separate from how much sugar you just ate.

That reframes insulin resistance as a storage problem. Rural Okinawans on high-carbohydrate, low-fat traditional diets had very low diabetes rates despite heavy rice intake before Western foods arrived. The villain stays consistent with earlier chapters: dietary fat and animal products more than any single isolated nutrient.

Neal Barnard’s trials comparing a low-fat vegan diet with standard American Diabetes Association advice found larger HbA1c drops and more medication reduction on the vegan side. Readers in low-carb camps will feel this chapter most, because it swaps the insulin-carbohydrate model for an intramyocellular-fat model that still lands on the same plant pattern.

In practice: In Barnard’s comparison, the low-fat vegan group cut HbA1c and diabetes medications more than the standard diabetes-diet group.

5

Reversal can start in weeks

Diet change can move measurable markers within weeks, undercutting the idea that chronic disease only declines one way.

Across the disease chapters Greger keeps returning to short clocks. Angina eased within weeks on Esselstyn’s protocol. LDL fell 30 to 40 percent within a month on a whole-food plant diet. Some blood-pressure work showed enough drop to taper medication in two weeks. Erectile function, used as a proxy for vessel health, improved in small trials on a similar timeline.

The point is practical. The book is not demanding a lifetime of blind faith before any payoff; it offers near-term, testable biomarker shifts. That attacks the fatalism of being told diabetes or hypertension is only permanent management.

He still separates marker and symptom reversal from cure. Plaque can shrink without vanishing. Diabetes can remit and return if the diet slides back. The chapter bridges evidence to experiment: measure, change food for a few weeks, measure again.

In practice: Greger cites LDL drops of 30 to 40 percent within a month and angina relief within weeks after oil, meat, and dairy leave the plate.

6

Daily Dozen over calorie math

A short daily add-list of food categories beats calorie counting or micronutrient tracking for lasting adherence.

After the dense disease half, Greger switches to behavior. The Daily Dozen is a checklist: beans, berries, other fruits, cruciferous vegetables, greens, other vegetables, flaxseed, nuts, herbs and spices, whole grains, a B12 supplement, plus exercise as a bonus.

The design prefers addition over subtraction. People resist long restriction and calorie math; flooding the day with the listed foods crowds weaker choices out by volume. He gives concrete portions, such as three bean servings and one tablespoon of ground flaxseed, tied to outcome data including flax and breast-cancer mortality signals in a Canadian screening cohort.

B12 is the frank concession. A washed-produce plant diet no longer reliably supplies what soil bacteria once did, so the one modern supplement is non-negotiable. The checklist is how the science becomes a Monday habit instead of a literature review.

In practice: Greger ties one daily tablespoon of ground flaxseed to lower breast-cancer mortality signals in the Canadian National Breast Screening Study cohort.